Plasma viral antigen linked to baseline severity of COVID-19
Sep 07, 2022
High levels of plasma viral antigen are linked to outcomes such as worse pulmonary status and longer time to hospital discharge.
Plant-based recombinant COVID-19 vaccine found to be effective
May 04, 2022
Vaccine efficacy ranged from 69.5% against symptomatic infection to 78.8% against moderate-to-severe disease.
Severe COVID-19 outcomes rare after primary vaccination
Jan 10, 2022
The risk was higher for people who were aged 65 years or older, immunosuppressed or had at least one of six underlying conditions.
Employment of nurses decreased early in COVID-19 pandemic
Jan 04, 2022
Employment rebounded during the course of 2020, apart from nursing homes, where it remained lower in June 2021 than February 2020.
Increase in blood pressure observed during COVID-19 pandemic
Dec 06, 2021
Mean changes each month during the pandemic ranged from 1.10 to 2.50 mm Hg for systolic BP, 0.14 to 0.53 mm Hg for diastolic BP.
More than 2 million COVID-19 home test kits recalled due to false-positive results
Nov 12, 2021
Thirty-five reports of false-positive results were sent to the FDA, but no deaths have been reported.
Guideline addresses diagnosis, evaluation of chest pain in adults
Nov 02, 2021
Chest pain can extend beyond the chest; patients experiencing chest pain or equivalent should seek medical help immediately.
AHA advises obstructive sleep apnea screening for those with cardiovascular risk, conditions
Jun 21, 2021
People with cardiovascular risk factors or conditions should be screened for obstructive sleep apnea, according to a scientific statement issued by the American Heart Association and published online June...
Inhaled nitrous oxide explored for treatment-resistant depression
Jun 10, 2021
In a phase 2 trial, 25% nitrous oxide was comparable with 50% nitrous oxide for reducing symptoms, but with fewer adverse effects.
Review of booster shots for Moderna, J&J vaccines just weeks away: Fauci
Sep 20, 2021
Fauci says that data on booster shots for those vaccines are only a few weeks away from a review by the FDA.